In contrast, the loss of PTEN occurs in 55% of GCB-DLBCLs, and AKT activation in GCB-DLBCL cells is frequently associated with the PTEN loss, which makes tumor cells addicted to oncogenic PI3K signaling [7]. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.